Search

Your search keyword '"Sitbon, Olivier"' showing total 1,411 results

Search Constraints

Start Over You searched for: Author "Sitbon, Olivier" Remove constraint Author: "Sitbon, Olivier"
1,411 results on '"Sitbon, Olivier"'

Search Results

4. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

5. Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?

7. Expert management of congenital portosystemic shunts and their complications

10. Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting

12. 2022 Update of indications and contraindications for lung transplantation in France

13. Evaluación multiparamétrica de la función ventricular derecha en la hipertensión arterial pulmonar asociada a cardiopatías congénitas

16. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

17. Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome

18. Incidental finding of elevated pulmonary arterial pressures during liver transplantation and postoperative pulmonary complications

19. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

20. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

22. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

23. Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.

24. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.

26. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency

28. Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

29. Corrigendum to ‘Expert management of congenital portosystemic shunts and their complications’ [JHEP Reports 6 (2024)]

32. ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

33. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

34. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

35. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

38. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

39. Portopulmonary hypertension in the current era of pulmonary hypertension management

41. Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France

42. Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents

43. Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension (CTEPH) with mixed anatomical lesions: a proof of concept

45. Characteristics in patients with inoperable CTEPH and a good hemodynamic outcome post-BPA

Catalog

Books, media, physical & digital resources